CD19 Tyrosine-mediated Signal Transduction in vivo
CD19 Tyrosine-mediated Signal Transduction in vivo
批准号:
8079028
负责人:
LOUIS B JUSTEMENT
金额:
$35.53万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2013-06-30
关键词:
AdhesionsAdoptive TransferAffinityAntibody FormationAntigen-Antibody ComplexAntigensAutoantibodiesAutoimmune DiseasesAutoimmunityB-Cell ActivationB-LymphocytesBloodBlood CirculationCD19 geneCD19 tyrosineCell Surface ReceptorsCellsDataDefectDendritic CellsDendritic cell activationFailureFollicular Dendritic CellsGenerationsGoalsHomingHost DefenseHourHumanImmunityImmunizationImmunoglobulin MImmunologic MemoryInfectionIntegral Membrane ProteinKidney DiseasesLeadLinkLupusMature B-LymphocyteMediatingMemory B-LymphocyteModelingMusPathway interactionsPhysiologicalPhysiologyProcessProductionProteinsPublishingRecoveryRecruitment ActivityRegulationReportingRoleSLEB1 geneSclerodermaSequence AnalysisSignal TransductionSiteSpleenStructure of germinal center of lymph nodeTestingTransgenesVaccinationVaccinesVasculitisbasecell motilityin vivomacrophagepathogenpublic health relevancereconstitutionresearch studyresponsetooltrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): B lymphocytes are required for host defense against infectious pathogens but abnormal activation of B cells can lead to autoimmunity. Thus, B cells are important in a wide range of physiologic and pathophysiologic processes. Mature B cells in the spleen enter into one of two compartments, the marginal zone or the follicular. Marginal zone B cells are responsible for rapid responses to pathogens that have reached the circulation. Follicular B cells are recruited into germinal centers, where affinity maturation and the generation of memory B cells lead to heightened responses upon subsequent encounters with a pathogen, which is crucial to immunization by vaccines. Mice lacking CD19, a B cell surface receptor, fail to form marginal zone B cells or germinal centers and have a propensity to produce autoantibodies. Our new data demonstrate that lack of marginal zone B cells results in defects in other components of the marginal zone, including marginal zone macrophages and dendritic cells. However, the macrophages and dendritic cells reappear following reconstitution of the marginal zone B cells by adoptive transfer of wild type B cells. Aim 1 will dissect the mechanisms by which CD19 on B cells regulates the differentiation of MZ B cells, and thereby other constituents of the marginal zone. Additional new preliminary data suggest that that failure to form germinal centers is associated with a failure of activation of Follicular Dendritic Cells (FDC) in CD19-/- mice. Adoptive transfer of wild type B cells also reconstitutes the ability to activate FDC in CD19-/- recipient mice, which recover the ability to form germinal centers. In Aim 2, we will test three hypotheses as to how CD19- dependent mechanisms regulate FDC: through activation of follicular B cells, through effects on the marginal zone that control delivery of antigen to FDC, and through formation of immune complexes. In Aim 3, we will determine how CD19 regulates autoimmunity by experiments to test the role of CD19 in central selection, selection in the periphery, and in a model of autoimmunity. These aims are proposed not just to understand the function of CD19, but to use CD19 to probe basic mechanisms that are fundamental to immunization and protection from pathogens, without autoimmunity. Public Health Relevance: The marginal zone of the spleen is required for survival of infections that have reached the blood while germinal centers are of fundamental importance in vaccination and immunological memory. Despite their crucial roles in protection from infections, the marginal zone and the germinal center responses are poorly understood. This project will use CD19, a protein expressed on B lymphocytes that is required for both types of response, as a tool to investigate the functions of B cells in the marginal zone and in germinal centers in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification and Analysis of the Physiological Ligand for TLT2
-
批准号:8568235
-
项目类别:
-
资助金额:$20.7万
-
财政年份:2013
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8081969
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2010
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7612425
-
项目类别:
-
资助金额:$6.71万
-
财政年份:2008
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7191849
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7367189
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:8030421
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7586201
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
Regulation of B Lymphocyte Survival and Differentiation by HSH2
-
批准号:7775050
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2007
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7647892
-
项目类别:
-
资助金额:$36.25万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7533208
-
项目类别:
-
资助金额:$36.25万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:8289609
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
CD19 Tyrosine-mediated Signal Transduction in vivo
-
批准号:7880585
-
项目类别:
-
资助金额:$35.89万
-
财政年份:1998
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6631860
-
项目类别:
-
资助金额:$23.46万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2376381
-
项目类别:
-
资助金额:$15.58万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2849455
-
项目类别:
-
资助金额:$19.37万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6373408
-
项目类别:
-
资助金额:$21.73万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6169791
-
项目类别:
-
资助金额:$20.21万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:6510549
-
项目类别:
-
资助金额:$22.77万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2667746
-
项目类别:
-
资助金额:$16.2万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
MOLECULAR MECHANISMS MEDIATING CD22 ACCESSORY FUNCTION
-
批准号:2072678
-
项目类别:
-
资助金额:$15.31万
-
财政年份:1995
-
负责人:LOUIS B JUSTEMENT
-
依托单位:
海外基金